Mark your calendars now – those leftover OTC and prescriptions in your medicine cabinet have got to go!
Chances are, if you open your medicine cabinet, you’ll find some some leftover medication that “might come in handy someday.” The reality is, those medications may have expired and are either ineffective or may cause more harm than you know. With cold and flu season upon us, it’s a great time to purge the medicine cabinet. Better to prepare now than scramble when you are sick. Clean out clutter and stock up on the staples!
With such hectic schedules, even the most together families can get frazzled. What’s a busy family to do in order to keep their cool? Award winning health, nutrition and lifestyle expert Sharon Liao is here to help! She is available to provide helpful tips to help families stay organized and on top of their hectic schedules, especially when it comes to meal times. Sharon is ready to discuss everything from time management and juggling family time around hectic schedules, to tips on being efficient during meal times and how all families can stay on the right nutrition and fitness track.
The Ad Council, the largest producer of public service campaigns in the U.S., in partnership with Viacom, home to premier global brands in media and entertainment, and non-profit leader Facing Addiction today launched the PSA campaign “LISTEN” to ignite a national conversation about drug and alcohol addiction as a public health epidemic, and empower those impacted by substance use disorders.
While past PSA campaigns have traditionally focused on the perspective of those at risk, urging them to eliminate all substance use, “LISTEN” addresses the support system of people who are also affected by this crisis. Using powerful stories that portray the modern faces of addiction and recovery, the campaign looks to remove the stigma attached to substance misuse through the act of informed, compassionate listening. The campaign’s website, heretolisten.com, and Facing Addiction's Resource Hub provides important tools and information to help people start a productive conversation with their friends and loved ones and to support the more than 45 million Americans directly impacted by addiction.
To view the multimedia release go to:
http://www.multivu.com/players/English/8029751-ad-council-listen-psa-addiction-drug-alcohol-substance-abuse/
Federally funded research continues to spur progress against cancer; however, accelerating the pace of progress will require robust, sustained, and predictable annual funding increases for the National Institutes of Health (NIH), the National Cancer Institute (NCI), and the Food and Drug Administration (FDA). Additionally, strong financial support for the National Cancer Moonshot Initiative is required, according to the sixth annual American Association for Cancer Research (AACR) Cancer Progress Report, released today.
One of the most exciting new approaches to cancer treatment is cancer immunotherapy. As detailed in the report, the utility of immunotherapy is expanding rapidly. For example, on Aug. 1, 2015, one class of immunotherapeutics, checkpoint inhibitors, was initially approved for just two types of cancer—melanoma and lung cancer. As of Sept. 1, 2016, checkpoint inhibitors have been approved for treating six types of cancer—bladder cancer, head and neck cancer, Hodgkin lymphoma, kidney cancer, lung cancer, and melanoma.
To view the multimedia release go to:
http://www.multivu.com/players/English/7911951-aacr-2016-cancer-progress-report/
USANA Health Sciences is pleased to announce an innovative technological advancement: its U.S. patent-pending USANA InCelligence Technology™. This exclusive cell-signaling technology—now found in various USANA® products—is designed to help your body’s cells renew and protect themselves in unique and powerful ways, representing a monumental leap forward in cellular nutrition and overall wellness.*
“USANA continues to build a reputation as an innovator in the science of cellular health and nutritional supplementation,” says USANA Founder Dr. Myron Wentz. “With USANA’s InCelligence Technology, we are ensuring that our company remains on the cutting-edge of nutritional supplementation.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7736551-usana-incelligence-technology/
The health of babies in the United States has taken a step backward as the nation’s preterm birth rate worsened for the first time in eight years, the March of Dimes said today. The U.S. earned a “C” grade on the latest March of Dimes Premature Birth Report Card amidst widening differences in prematurity rates across different races and ethnicities.
“The 2016 March of Dimes Report Card demonstrates that there is an unfair burden of premature birth among specific racial and ethnic groups as well as geographic areas,” says Dr. Jennifer L. Howse, president of the March of Dimes. “The March of Dimes strives for a world where every baby has a fair chance, yet we see this is not the reality for many mothers and babies. Babies in this country have different chances of surviving and thriving simply based on the circumstances of their birth.”
The U.S. preterm birth rate went up from 9.57 to 9.63 in 2015, according to final data from the National Center for Health Statistics (NCHS). Across the country, preterm birth rates were nearly 48 percent higher among black women and more than 15 percent higher among American Indian/Alaska Native women compared to white women.
To view the multimedia release go to:
http://www.multivu.com/players/English/7945951-march-of-dimes-premature-birth-report/
Blood cancers are the third leading cause of cancer deaths in the U.S. However, many Americans are unaware of the impact of these cancers, including leukemia, lymphoma and myeloma, which affect the bone marrow, the blood cells, the lymph nodes and other parts of the lymphatic system.
A new survey commissioned by The Leukemia & Lymphoma Society (LLS) reveals more than four in five adults (82%) are surprised that blood cancers are the third leading cancer killer of Americans. Further, nearly four in five adults (78%) are surprised that acute lymphocytic leukemia (ALL) is the most common cancer in children and young adults under age 20.
To view the multimedia release go to:
https://www.multivu.com/players/English/8128551-lls-blood-cancer-awareness-month/
nanobébé, a brand dedicated to revolutionizing the infant feeding industry, today announced the launch of its much-anticipated sleek and modern ecosystem of health-focused feeding essentials for today’s 21st century parents, poised to be hot baby registry items this year. Breastfeeding moms can rejoice in the company’s flagship Breastmilk Bottle, the first and only baby bottle designed specifically to preserve essential breast milk nutrients. From pumping, storing, warming to feeding, the award-winning nanobébé Breastmilk Bottle protects the breast milk and preserves its nutritional value.
“When moms warm breast milk in the traditional way, there is a good chance that they are unknowingly damaging the nutritional and immunity-boosting properties of the milk. Additionally, the milk is likely heated unevenly, causing hot spots, which can harm the baby,” said Rallie McAllister, MD, MPH, nanobébé SpokesDoctor, family physician and coauthor of The Mommy MD Guide to Your Baby’s First Year. “nanobébé’s bottles are biomedically engineered with a concave shape that spreads the breast milk into a thin layer and allows it to warm at safe temperatures, protecting nutrients from damage and preventing hot spots.” The nanobébé Breastmilk Bottle warms stored breast milk quickly, twice as fast as standard bottles.
To view the multimedia release go to:
https://www.multivu.com/players/English/8260351-nanobebe-infant-breastfeeding-line/
The CDC Foundation, actor Idris Elba and a global team of African soccer stars, international health and aid organizations today announced the launch of Africa United, a global health communications campaign aimed at preventing the spread of Ebola in West Africa. Africa United will leverage campaign partners and celebrities to provide critical education and resources for the people of West Africa.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7390651-cdc-foundation-we-are-africa-united-ebola-health-workers/
Brock Beauty, Inc.’s bestselling hair vitamin Hairfinity® has been helping women grow healthier hair for more than 10 years. This Mother’s Day, founder Tai Lawrence is giving the world an intimate look into the inspiration behind the product – her daughter Jasmine – in a two minute short film called “They Learn From You.”
In “They Learn From You,” Tai describes her hair journey and shares her experience raising her daughter. “I struggled with my hair growing up. All of the chemicals, products and heat styling really did a number on the health of my hair,” said Tai Lawrence Brock Beauty Founder and visionary behind Hairfinity. “Most women have a childhood experience that defines their relationship with their hair. I wanted my little girl to feel good about her healthy hair and not be concerned about whether it was long, short, curly, textured or straight. That’s why Hairfinity® was created.”
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7522951-brock-beauty-hairfinity-hair-supplement/
Boston Scientific (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval for the SYNERGY™ Bioabsorbable Polymer Drug-Eluting Stent System (BP-DES) for the treatment of coronary artery disease.
With this FDA approval, Boston Scientific will commence commercialization of the first and only BP-DES in the U.S. Notably, both the drug coating and the polymer – which modulates drug release – are fully absorbed shortly after drug elution is complete at three months.
The SYNERGY Stent provides synchronized drug and polymer absorption. It is designed to enable more rapid and complete arterial healing, and to thereby reduce the risk of complications associated with long-term polymer exposure compared to currently-used drug-eluting stents (DES) with permanent polymers.
To view the multimedia release go to:
http://www.multivu.com/players/English/7223456-boston-scientific-fda-approval-synergy/
